ESTHMR إستثمر

Memphis Pharmaceutical & Chemical Industries MPCI

ممفيس للادوية والصناعات الكيماوية

Health Care & PharmaceuticalsEgyptian Exchange

373.00 EGP

+3.04%

Close of Thu 12 Nov 2026

Market value
EGP 8.60bn
Highest and lowest close in a year
130.14 – 446.00
Shares traded in the session
520,495
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Memphis Pharmaceutical and Chemical Industries is a Cairo-based company operating in the pharmaceuticals, biotechnology, and life sciences sector, focusing on pharmaceuticals. Established in July 1940 and listed on the Egyptian Exchange since September 1995, it is majority-controlled by Holding Co for Pharmaceuticals with a 60.0384% stake. The company holds an 8.8% stake in Arab Company for Pharmaceutical and Medicinal Plants and 5.0% in Medical Profession Investment Co.

Its record at the exchange

Across 868 filings from 2010 to 2026, the company experienced trading suspensions 27 times and resumptions 24 times, with 2016 being its most active year at 68 filings. Out of 68 reported cumulative profit-or-loss periods from 2014 to 2026, 14 were loss-making. Its reported net results have ranged from a low of -47 million EGP in FY 2018 (to 30 Jun) to a high of 505 million EGP in FY 2025 (to 30 Jun).

Its latest filings at the exchange

  1. Memphis Pharmaceuticals (MPCI.CA) Declares Cash Dividends
  2. Shareholders' meetingMemphis Pharmaceuticals (MPCI.CA) - AGM Minutes (before Certification)
  3. Shareholders' meetingMemphis Pharmaceuticals (MPCI.CA) - AGM Resolutions
  4. Board decisionsMemphis Pharmaceuticals (MPCI.CA) - Decisions of the BoD Meeting
  5. Auditor or accountsMemphis Pharmaceuticals (MPCI.CA) - Company's Reply on the Central Authority of Accountancy Report
  6. Board decisionsMemphis Pharmaceuticals (MPCI.CA) - Disclosure Form for the BoD & the Shareholders' Structure
  7. Shareholders' meetingRelease from Memphis Pharmaceuticals (MPCI.CA) Concerning the AGM Invitation
  8. ResultsMemphis Pharmaceuticals (MPCI.CA) Reports its Financial Results for the Period Ending on 30/06/2026

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Insider / Board Sold200 (less than 0.01% of the company)Bulletin ↗
  2. Insider / Board Sold140 (less than 0.01% of the company)Bulletin ↗
  3. Insider / Board Bought225 (less than 0.01% of the company)Bulletin ↗
  4. Insider / Board Bought1,340 (less than 0.01% of the company)Bulletin ↗
  5. Insider / Board Sold1,497 (less than 0.01% of the company)Bulletin ↗
  6. Insider / Board Sold3 (less than 0.01% of the company)Bulletin ↗
  7. Insider / Board Sold50 (less than 0.01% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 15 Nov 2026.